Report cover image

Ferring Holding SA - Strategic SWOT Spotlight

Publisher Quaintel Research
Published Aug 27, 2024
Length 49 Pages
SKU # QTELR19119632

Description

Ferring Holding SA - Strategic SWOT Spotlight


Ferring Holding SA - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Ferring Holding SA's business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.

Key Highlights

Ferring Holding SA is a global biopharmaceutical company that specializes in developing innovative treatments for various medical conditions. The company offers a wide range of products and services, including medications for reproductive health, urology, gastroenterology, endocrinology, and orthopedics. They also provide treatments for rare diseases and conditions such as hemophilia and growth hormone deficiency. In addition to pharmaceuticals, Ferring Holding SA also offers medical devices and diagnostic tools for fertility and pregnancy monitoring. The company is committed to improving the lives of patients and their families by continuously researching and developing new and effective treatments. They also provide educational resources and support programs for patients and healthcare professionals. Founded in 1950, the company is headquartered in Saint-Prex, Vaud, Switzerland.

Ferring Holding SA in the News:-
  • 17-May-2024 - Ferring announces results demonstrating the efficacy and safety of follitropin delta for women undergoing in vitro fertilisation using an agonist protocol
  • 18-Apr-2024 - Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal
  • 11-Dec-2023 - Ferring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement
  • 18-Sep-2023 - Ferring Named in Fortune's 2023 Change the World List
  • 24-Aug-2023 - Ad hoc announcement pursuant to Art. 53 LR Royalty Pharma and Ferring Pharmaceuticals enter into US $500 million royalty agreement for new intravesical gene therapy Adstiladrin
Scope

Company Fundamentals:- These fundamentals offer valuable insights into Ferring Holding SA's operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.

Reasons to Buy
  • Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Table of Contents

49 Pages
Table of Contents
Tables
Charts
Ferring Holding SA - Key Company Facts
Ferring Holding SA - Company Description
Ferring Holding SA - Top Executives
Ferring Holding SA - Head Office & Locations
Head Office - Country
Ferring Holding SA - Products and Services
Products
Services
Ferring Holding SA - Corporate Strategy
Ferring Holding SA - Business Description
Reproductive Health and Fertility Treatments
Gastroenterology and Urology Treatments
Ferring Holding SA - ESG Spotlight
Environment
Social
Corporate Governance
Ferring Holding SA - SWOT Spotlight
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
AbbVie Inc
Key Company Facts
Company Description
Key Financials:
Bayer Aktiengesellschaft
Key Company Facts
Company Description
Key Financials:
Merck KGaA
Key Company Facts
Company Description
Key Financials:
Takeda Pharmaceutical Company Limited
Key Company Facts
Company Description
Key Financials:
Cosmo Pharmaceuticals NV
Key Company Facts
Company Description
Key Financials:
Ferring Holding SA - In the News
17-May-2024- Ferring announces results demonstrating the efficacy and safety of follitropin delta for women undergoing in vitro fertilisation using an agonist protocol
18-Apr-2024- Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal
11-Dec-2023- Ferring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement
18-Sep-2023- Ferring Named in Fortune's 2023 Change the World List
24-Aug-2023- Ad hoc announcement pursuant to Art. 53 LR Royalty Pharma and Ferring Pharmaceuticals enter into US $500 million royalty agreement for new intravesical gene therapy Adstiladrin
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Research Methodology
Disclaimer
Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us